Get started
Author

Kaitlyn Bejar

Observed name: Kaitlyn R. Bejar
ORCID: 0000-0002-3911-9290
Observed ORCID: 0000-0002-3911-9290
OpenAlex ID: A5019566762
Paracrine Secretion of Transforming Growth Factor β by Ductal Cells Promotes Acinar-to-Ductal Metaplasia in Cultured Human Exocrine Pancreas Tissues
2017 · Naoki Akanuma, Jun Liu, et al. · Pancreas · 15
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2024 · Jordan P. Hartig, Kaitlyn Bejar, et al. · Cancer Research Communications · 9
N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2024 · Joseph E. Ippolito, Jordan P. Hartig, et al. · Molecular Cancer Research · 8
Multi-modal spatial glycomic analysis of lymphoid aggregates in prostate and pancreatic cancer tissues
2026 · Kameisha V. Rashford, Caroline G. Kittrell, et al. · Frontiers in Oncology
PDF
Rapid Single-Cell N-glycosylation Profiling of Circulating Human Immune Cells by Mass Spectrometry Imaging
2026 · Lyndsay E. A. Young, Lauren E. Hill, et al. · Journal of the American Society for Mass Spectrometry
Supplementary Figure S7 from N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2026 · Joseph E. Ippolito, Jordan P. Hartig, et al.
Supplementary Figure S2 from N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2026 · Joseph E. Ippolito, Jordan P. Hartig, et al.
Supplementary Figure S6 from N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2026 · Joseph E. Ippolito, Jordan P. Hartig, et al.
Supplementary Figure S8 from N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2026 · Joseph E. Ippolito, Jordan P. Hartig, et al.
Supplementary Figure S1 from N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2026 · Joseph E. Ippolito, Jordan P. Hartig, et al.
Supplementary Figure S4 from N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2026 · Joseph E. Ippolito, Jordan P. Hartig, et al.
Supplementary Table S3 from N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2026 · Joseph E. Ippolito, Jordan P. Hartig, et al.
Supplementary Figure S5 from N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2026 · Joseph E. Ippolito, Jordan P. Hartig, et al.
Supplementary Figure S3 from N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2026 · Joseph E. Ippolito, Jordan P. Hartig, et al.
Supplementary Table S2 from N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
2026 · Joseph E. Ippolito, Jordan P. Hartig, et al.
Figure S4 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Table S6 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S13 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Table S1 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S3 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Table S3 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S12 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S5 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S18 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S6 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Works count: 113
Citation count: 32
H-index: 3
I10-index: 1
Year
Topic
Type